acute gout attack
Conditions
Interventions
Control:Placebo + 0.6 mg Oral Colchicine
Treatment:Mahajak Oil + 0.6 mg Oral Colchicine
Sponsors
Artina Pinta and all other members of the research group
Eligibility
Sex/Gender
All
Age
31 Years to 85 Years
Inclusion criteria
Inclusion criteria: Patients were eligible for the trial if they had been clinically diagnosed with acute gout arthritis according to the Rome criteria for gout, i.e. with at least 2 of the following 4 criteria: (1) serum urate (SU) level >7 mg/dL in men or >6 mg/dL in women; (2) presence of tophi; (3) presence of monosodium urate (MSU) crystals in synovial fluid or tissues; (4) history of painful joint swelling with abrupt onset and remission within 2 weeks.11 Male or female patients aged 20 years or above, without any diseases or contraindications to the interventions, no skin diseases, and no prior joint accidents were included. Patients were required to give written informed consent and to agree to follow the protocol.
Exclusion criteria
Exclusion criteria: Patients with secondary gout or other types of arthritis such as rheumatoid arthritis, osteoarthritis, or septic arthritis, as well as those suffering from SLE were excluded from the study. Patients with a history of hypersensitivity to herbal medicines were also excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Joint Circumference;Joint Motion Angle; | — |
Countries
Thailand
Contacts
Public ContactArtina Pinta
Kranuan Crown Prince Hospital
Outcome results
None listed